Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
26.12
+0.84 (3.32%)
At close: Mar 9, 2026, 4:00 PM EDT
26.14
+0.02 (0.08%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $1.40 billion as of March 9, 2026. Its market cap has increased by 329.91% in one year.
Market Cap
1.40B
Enterprise Value
1.11B
1-Year Change
329.91%
Ranking
Category
Stock Price
$26.12
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $1.40B, an increase of 107.43%. That is a compound annual growth rate of 63.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.36B | -30.38% |
| Dec 31, 2025 | 1.95B | 469.46% |
| Dec 31, 2024 | 342.27M | -49.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trevi Therapeutics | 1.50B |
| Rapport Therapeutics | 1.46B |
| AtaiBeckley | 1.41B |
| Monte Rosa Therapeutics | 1.40B |
| Savara | 1.34B |
| Immatics | 1.34B |
| Corvus Pharmaceuticals | 1.33B |
| MBX Biosciences | 1.32B |